Larry Odekirk
Family Medicine · Castle Rock, CONPI 1245210301
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $5,500 of the $6,795 with a category attached, or 80.9%. It is spread thinly across 34 manufacturers, the largest accounting for just 24.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $3,267 and has fallen 92.4% since, to $248 in 2023. Among family medicine clinicians in CO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 157 payments — averaging $43.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Radius Health, Inc.$2K
- AstraZeneca$855
- AbbVie$750
- Novo Nordisk$460
- Eisai Inc.$435
- Amgen$307
- plus $2K from 28 others
Across 1,199 payments — averaging $5271.11 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Pfizer$2M
- Modernatx, Inc.$1.3M
- Regeneron$1M
- AbbVie$718K
- Merck$696K
- Bavarian Nordic A/s$223K
- plus $410K from 7 others
What the payments were for
- Travel & lodging$1,24018%
- Food & beverage$5,50081%
- Education$351%
- Gifts$200%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Radius Health, Inc. | 11 | $1,627 |
| AstraZeneca | 25 | $855 |
| AbbVie(2 entities) | 24 | $750 |
| Novo Nordisk | 16 | $460 |
| Eisai Inc. | 9 | $435 |
| Amgen | 6 | $307 |
| Amarin Pharma, Inc. | 10 | $256 |
| Therapeuticsmd, Inc. | 2 | $253 |
| Otsuka America Pharmaceutical, Inc. | 2 | $235 |
| Johnson & Johnson | 4 | $163 |
| Esperion Therapeutics, Inc. | 3 | $154 |
| Daiichi Sankyo Inc. | 2 | $142 |
| Biohaven Pharmaceuticals, Inc. | 2 | $133 |
| Astellas Pharma US Inc | 1 | $125 |
| E.r. Squibb & Sons, L.L.C. | 1 | $121 |
| Neurocrine Biosciences, Inc. | 1 | $113 |
| Avanir Pharmaceuticals, Inc. | 5 | $105 |
| Bausch Health US, LLC | 5 | $88 |
| Kowa Pharmaceuticals America, Inc. | 5 | $76 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $61 |
| Merck | 2 | $50 |
| Novartis | 2 | $40 |
| Lilly USA, LLC | 3 | $38 |
| Pfizer | 2 | $31 |
| Fidia Pharma USA Inc. | 2 | $31 |
| GSK | 1 | $21 |
| Alkermes, Inc. | 1 | $20 |
| Shire North American Group Inc | 1 | $19 |
| Endo Pharmaceuticals Inc. | 1 | $17 |
| Alfasigma USA, Inc. | 1 | $16 |
| Bardy Diagnostics, Inc. | 1 | $15 |
| Teva Pharmaceuticals USA, Inc. | 1 | $14 |
| Jazz Pharmaceuticals Inc. | 1 | $13 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,795 in reported general payments places this provider in the 95th percentile of 2,079 family medicine providers in Colorado.
Other family medicine in Castle Rock
- Belton HallmarkCastle Rock$19K
- Aaron BlockCastle Rock$17K
- Ethan LazarusDenver$688K
- Michael de NardisLarkspur$335K
- Matthew YoungColorado Springs$270K
- Mark DeutchmanDenver$258K
- Kari UusinarkausWoodland Park$254K
- Michael MeekerUsaf Academy$174K
- Carolynn Francavilla BrownLakewood$174K
- Lawrence AndrewsColorado Springs$102K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.